{"result": "(\"entity\"<|>LIGHTHART-MELIS GC<|>PERSON<|>Ligthart-Melis GC is a researcher involved in studies related to nutritional support in esophageal cancer patients.)\n##\n(\"entity\"<|>WEIJS PJ<|>PERSON<|>Weijs PJ is a researcher contributing to the studies on nutritional support and postoperative complications in esophageal cancer.)\n##\n(\"entity\"<|>TE BOVELDT ND<|>PERSON<|>Te Boveldt ND is a researcher who has co-authored studies on nutritional interventions for esophageal cancer patients.)\n##\n(\"entity\"<|>BUSKERMOLEN S<|>PERSON<|>Buskermolen S is a researcher involved in the investigation of nutritional support in esophageal cancer surgery.)\n##\n(\"entity\"<|>EARTHMAN CP<|>PERSON<|>Earthman CP is a researcher studying the effects of nutritional support on postoperative outcomes in esophageal cancer patients.)\n##\n(\"entity\"<|>VERHEUL HM<|>PERSON<|>Verheul HM is a researcher who has contributed to studies on nutritional support in the context of esophageal cancer.)\n##\n(\"entity\"<|>WANG G<|>PERSON<|>Wang G is a researcher who has compared different nutritional approaches for patients with esophageal cancer.)\n##\n(\"entity\"<|>CHEN H<|>PERSON<|>Chen H is a researcher involved in studies comparing nutritional methods for esophageal cancer patients.)\n##\n(\"entity\"<|>LIU J<|>PERSON<|>Liu J is a researcher who has participated in studies on postoperative nutrition for esophageal cancer patients.)\n##\n(\"entity\"<|>MA Y<|>PERSON<|>Ma Y is a researcher contributing to the analysis of nutritional strategies in esophageal cancer treatment.)\n##\n(\"entity\"<|>JIA H<|>PERSON<|>Jia H is a researcher involved in studies comparing early and delayed enteral nutrition in esophageal cancer patients.)\n##\n(\"entity\"<|>MANBA N<|>PERSON<|>Manba N is a researcher studying the effects of early enteral nutrition in esophageal cancer surgery.)\n##\n(\"entity\"<|>KOYAMA Y<|>PERSON<|>Koyama Y is a researcher who has investigated nutritional support in the context of esophageal cancer surgery.)\n##\n(\"entity\"<|>KOSUGI S<|>PERSON<|>Kosugi S is a researcher involved in studies on nutritional interventions for esophageal cancer patients.)\n##\n(\"entity\"<|>ISHIKAWA T<|>PERSON<|>Ishikawa T is a researcher studying the impact of early enteral nutrition on postoperative recovery in esophageal cancer.)\n##\n(\"entity\"<|>ICHIWAKA H<|>PERSON<|>Ichikawa H is a researcher contributing to studies on nutritional support in esophageal cancer surgery.)\n##\n(\"entity\"<|>MINAGAWA M<|>PERSON<|>Minagawa M is a researcher involved in the analysis of nutritional strategies for esophageal cancer patients.)\n##\n(\"entity\"<|>PENG J<|>PERSON<|>Peng J is a researcher who has conducted a meta-analysis on nutritional approaches for esophageal cancer patients.)\n##\n(\"entity\"<|>CAI J<|>PERSON<|>Cai J is a researcher involved in studies comparing enteral and parenteral nutrition for esophageal cancer patients.)\n##\n(\"entity\"<|>NIU ZX<|>PERSON<|>Niu ZX is a researcher contributing to the analysis of nutritional support in esophageal cancer treatment.)\n##\n(\"entity\"<|>CHEN LQ<|>PERSON<|>Chen LQ is a researcher involved in studies on nutritional strategies for patients with esophageal cancer.)\n##\n(\"entity\"<|>BARLOW R<|>PERSON<|>Barlow R is a researcher who has conducted trials on early enteral nutrition for patients undergoing gastrointestinal surgery.)\n##\n(\"entity\"<|>PRICE P<|>PERSON<|>Price P is a researcher involved in studies on nutritional support in surgical patients.)\n##\n(\"entity\"<|>REID TD<|>PERSON<|>Reid TD is a researcher contributing to studies on early enteral nutrition in surgical patients.)\n##\n(\"entity\"<|>HUNT S<|>PERSON<|>Hunt S is a researcher involved in trials assessing nutritional support in upper gastrointestinal surgery.)\n##\n(\"entity\"<|>CLARK GW<|>PERSON<|>Clark GW is a researcher who has studied the effects of nutritional interventions in surgical patients.)\n##\n(\"entity\"<|>HAVARD TJ<|>PERSON<|>Havard TJ is a researcher contributing to studies on early enteral nutrition in surgical contexts.)\n##\n(\"entity\"<|>PUNTIS MC<|>PERSON<|>Puntis MC is a researcher involved in studies on nutritional support for surgical patients.)\n##\n(\"entity\"<|>LEWIS WG<|>PERSON<|>Lewis WG is a researcher who has studied complications related to feeding tubes in cancer patients.)\n##\n(\"entity\"<|>WRIGHT GP<|>PERSON<|>Wright GP is a researcher involved in studies on esophagectomy and its complications.)\n##\n(\"entity\"<|>FOSTER SM<|>PERSON<|>Foster SM is a researcher studying complications related to feeding jejunostomy tubes in cancer patients.)\n##\n(\"entity\"<|>CHUNG MH<|>PERSON<|>Chung MH is a researcher who has investigated complications in patients with gastroesophageal cancer.)\n##\n(\"entity\"<|>BOWEN TS<|>PERSON<|>Bowen TS is a researcher studying skeletal muscle wasting in cancer patients.)\n##\n(\"entity\"<|>SCHULER G<|>PERSON<|>Schuler G is a researcher involved in studies on exercise training and its impact on cancer patients.)\n##\n(\"entity\"<|>ADAMS V<|>PERSON<|>Adams V is a researcher studying the molecular pathophysiology of cachexia and sarcopenia in cancer patients.)\n##\n(\"entity\"<|>LONBRO S<|>PERSON<|>LÃ¸nbro S is a researcher who has reviewed the effects of resistance training on cancer patients' lean body mass.)\n##\n(\"entity\"<|>MARTIN L<|>PERSON<|>Martin L is a researcher studying risk factors for weight loss in esophageal cancer survivors.)\n##\n(\"entity\"<|>LAGERGREN P<|>PERSON<|>Lagergren P is a researcher involved in studies on long-term weight change after esophageal cancer surgery.)\n##\n(\"entity\"<|>D'JOURNO XB<|>PERSON<|>D'Journo XB is a researcher studying the prognostic impact of weight loss in esophageal cancer survivors.)\n##\n(\"entity\"<|>OUATTARA M<|>PERSON<|>Ouattara M is a researcher contributing to studies on weight loss after esophagectomy.)\n##\n(\"entity\"<|>LOUNDOU A<|>PERSON<|>Loundou A is a researcher involved in studies on postoperative outcomes in esophageal cancer patients.)\n##\n(\"entity\"<|>TROUSSE D<|>PERSON<|>Trousse D is a researcher studying the effects of weight loss on cancer patient outcomes.)\n##\n(\"entity\"<|>DAHAN L<|>PERSON<|>Dahan L is a researcher involved in studies on nutritional status in cancer patients.)\n##\n(\"entity\"<|>NATHALIE T<|>PERSON<|>Nathalie T is a researcher studying the correlation between nutritional status and surgical outcomes in cancer patients.)\n##\n(\"entity\"<|>KOIZUMI M<|>PERSON<|>Koizumi M is a researcher studying ghrelin levels and weight loss after esophagectomy.)\n##\n(\"entity\"<|>HOSOYA Y<|>PERSON<|>Hosoya Y is a researcher involved in studies on postoperative weight loss in esophageal cancer patients.)\n##\n(\"entity\"<|>DEZAKI K<|>PERSON<|>Dezaki K is a researcher studying the hormonal responses related to weight loss in cancer patients.)\n##\n(\"entity\"<|>YADA T<|>PERSON<|>Yada T is a researcher involved in studies on postoperative outcomes in esophageal cancer.)\n##\n(\"entity\"<|>HOSODA H<|>PERSON<|>Hosoda H is a researcher studying the effects of hormonal levels on weight loss in cancer patients.)\n##\n(\"entity\"<|>KANGAWA K<|>PERSON<|>Kangawa K is a researcher involved in studies on ghrelin and its effects on weight loss in cancer patients.)\n##\n(\"entity\"<|>MIYAZAKI T<|>PERSON<|>Miyazaki T is a researcher studying the relationship between ghrelin levels and weight loss after esophagectomy.)\n##\n(\"entity\"<|>TANAKA N<|>PERSON<|>Tanaka N is a researcher involved in studies on postoperative weight loss in esophageal cancer patients.)\n##\n(\"entity\"<|>HIRAI H<|>PERSON<|>Hirai H is a researcher studying the effects of surgical interventions on weight loss in cancer patients.)\n##\n(\"entity\"<|>YOKOBORI T<|>PERSON<|>Yokobori T is a researcher involved in studies on weight loss and hormonal responses in esophageal cancer patients.)\n##\n(\"entity\"<|>SANO A<|>PERSON<|>Sano A is a researcher studying the impact of surgical procedures on weight loss in cancer patients.)\n##\n(\"entity\"<|>SAKAI M<|>PERSON<|>Sakai M is a researcher involved in studies on postoperative outcomes in esophageal cancer patients.)\n##\n(\"entity\"<|>DOKI Y<|>PERSON<|>Doki Y is a researcher studying the effects of esophageal substitution on weight loss in cancer patients.)\n##\n(\"entity\"<|>TAKACHI K<|>PERSON<|>Takachi K is a researcher involved in studies on postoperative outcomes in esophageal cancer patients.)\n##\n(\"entity\"<|>ISHIKAWA O<|>PERSON<|>Ishikawa O is a researcher studying the effects of surgical interventions on weight loss in esophageal cancer patients.)\n##\n(\"entity\"<|>MIYASHIRO I<|>PERSON<|>Miyashiro I is a researcher involved in studies on weight loss and surgical outcomes in esophageal cancer patients.)\n##\n(\"entity\"<|>SASAKI Y<|>PERSON<|>Sasaki Y is a researcher studying the relationship between surgical procedures and weight loss in cancer patients.)\n##\n(\"entity\"<|>OHIGASHI H<|>PERSON<|>Ohigashi H is a researcher involved in studies on postoperative weight loss in esophageal cancer patients.)\n##\n(\"entity\"<|>KARAGIANNI VT<|>PERSON<|>Karagianni VT is a researcher studying nutritional status before and after pancreatectomy for cancer patients.)\n##\n(\"entity\"<|>PAPALOIS AE<|>PERSON<|>Papalois AE is a researcher involved in studies on nutritional support in pancreatic cancer patients.)\n##\n(\"entity\"<|>TRIANTAFILLIDIS JK<|>PERSON<|>Triantafillidis JK is a researcher studying nutritional status and support in cancer patients.)\n##\n(\"relationship\"<|>LIGHTHART-MELIS GC<|>ESOPHAGEAL CANCER<|>Ligthart-Melis GC is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>WEIJS PJ<|>ESOPHAGEAL CANCER<|>Weijs PJ is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>TE BOVELDT ND<|>ESOPHAGEAL CANCER<|>Te Boveldt ND is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>BUSKERMOLEN S<|>ESOPHAGEAL CANCER<|>Buskermolen S is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>EARTHMAN CP<|>ESOPHAGEAL CANCER<|>Earthman CP is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>VERHEUL HM<|>ESOPHAGEAL CANCER<|>Verheul HM is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>WANG G<|>ESOPHAGEAL CANCER<|>Wang G is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>CHEN H<|>ESOPHAGEAL CANCER<|>Chen H is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>LIU J<|>ESOPHAGEAL CANCER<|>Liu J is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>MA Y<|>ESOPHAGEAL CANCER<|>Ma Y is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>JIA H<|>ESOPHAGEAL CANCER<|>Jia H is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>MANBA N<|>ESOPHAGEAL CANCER<|>Manba N is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>KOYAMA Y<|>ESOPHAGEAL CANCER<|>Koyama Y is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>KOSUGI S<|>ESOPHAGEAL CANCER<|>Kosugi S is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>ISHIKAWA T<|>ESOPHAGEAL CANCER<|>Ishikawa T is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>ICHIWAKA H<|>ESOPHAGEAL CANCER<|>Ichikawa H is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>MINAGAWA M<|>ESOPHAGEAL CANCER<|>Minagawa M is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>PENG J<|>ESOPHAGEAL CANCER<|>Peng J is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>CAI J<|>ESOPHAGEAL CANCER<|>Cai J is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>NIU ZX<|>ESOPHAGEAL CANCER<|>Niu ZX is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>CHEN LQ<|>ESOPHAGEAL CANCER<|>Chen LQ is involved in research related to esophageal cancer and nutritional support<|>7)\n##\n(\"relationship\"<|>BARLOW R<|>NUTRITIONAL SUPPORT<|>Barlow R is involved in research on early enteral nutrition for surgical patients<|>8)\n##\n(\"relationship\"<|>PRICE P<|>NUTRITIONAL SUPPORT<|>Price P is involved in research on early enteral nutrition for surgical patients<|>8)\n##\n(\"relationship\"<|>REID TD<|>NUTRITIONAL SUPPORT<|>Reid TD is involved in research on early enteral nutrition for surgical patients<|>8)\n##\n(\"relationship\"<|>HUNT S<|>NUTRITIONAL SUPPORT<|>Hunt S is involved in research on early enteral nutrition for surgical patients<|>8)\n##\n(\"relationship\"<|>CLARK GW<|>NUTRITIONAL SUPPORT<|>Clark GW is involved in research on early enteral nutrition for surgical patients<|>8)\n##\n(\"relationship\"<|>HAVARD TJ<|>NUTRITIONAL SUPPORT<|>Havard TJ is involved in research on early enteral nutrition for surgical patients<|>8)\n##\n(\"relationship\"<|>PUNTIS MC<|>NUTRITIONAL SUPPORT<|>Puntis MC is involved in research on early enteral nutrition for surgical patients<|>8)\n##\n(\"relationship\"<|>LEWIS WG<|>NUTRITIONAL SUPPORT<|>Lewis WG is involved in research on complications related to feeding tubes in cancer patients<|>6)\n##\n(\"relationship\"<|>WRIGHT GP<|>SURGERY<|>Wright GP is involved in research on esophagectomy and its complications<|>8)\n##\n(\"relationship\"<|>FOSTER SM<|>SURGERY<|>Foster SM is involved in research on complications related to feeding jejunostomy tubes in cancer patients<|>6)\n##\n(\"relationship\"<|>CHUNG MH<|>SURGERY<|>Chung MH is involved in research on complications in patients with gastroesophageal cancer<|>6)\n##\n(\"relationship\"<|>BOWEN TS<|>NUTRITIONAL SUPPORT<|>Bowen TS is involved in research on skeletal muscle wasting in cancer patients<|>7)\n##\n(\"relationship\"<|>SCHULER G<|>NUTRITIONAL SUPPORT<|>Schuler G is involved in research on exercise training and its impact on cancer patients<|>7)\n##\n(\"relationship\"<|>ADAMS V<|>NUTRITIONAL SUPPORT<|>Adams V is involved in research on skeletal muscle wasting in cancer patients<|>7)\n##\n(\"relationship\"<|>LONBRO S<|>NUTRITIONAL SUPPORT<|>LÃ¸nbro S is involved in research on the effects of resistance training on cancer patients' lean body mass<|>7)\n##\n(\"relationship\"<|>MARTIN L<|>ESOPHAGEAL CANCER<|>Martin L is involved in research on risk factors for weight loss in esophageal cancer survivors<|>7)\n##\n(\"relationship\"<|>LAGERGREN P<|>ES", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: of a randomized, controlled, multicen-\n    ter trial. Cancer. 2013; 119:3343-53.\n84. Ligthart-Melis GC, Weijs PJ, te Boveldt ND, Busker-\n    molen S, Earthman CP, Verheul HM, et al. Dieti-\n    cian-delivered intensive nutritional support is asso-\n    ciated with a decrease in severe postoperative\n    complications after surgery in patients with eso-\n    phageal cancer. Dis Esophagus. 2013; 26:587-93.\n85. Starr B, Davis S, Ayala-Peacock D, Blackstock WA,\n    Levine EA. Reassessment of the role of enteral tube\n    feedings for patients with esophageal cancer. Am\n    Surg. 2014; 80:752-8.\n86. Wang G, Chen H, Liu J, Ma Y, Jia H. A comparison\n    of postoperative early enteral nutrition with dela-\n    yed enteral nutrition in patients with esophageal\n    cancer. Nutrients. 2015; 7:4308-17.\n87. Manba N, Koyama Y, Kosugi S, Ishikawa T, Ichi-\n    kawa H, Minagawa M, et al. Is early enteral nutri-\n    tion initiated within 24 hours better for the posto-\n    perative course in esophageal cancer surgery? J\n    Clin Med Res. 2014; 6:53-8.\n88. Peng J, Cai J, Niu ZX, Chen LQ. Early enteral nutri-\n    tion compared with parenteral nutrition for eso-\n    phageal cancer patients after esophagectomy: a\n    meta-analysis. Dis Esophagus. 2016; 29:333-41.\n\n89. Barlow R, Price P, Reid TD, Hunt S, Clark GW, Ha-\n    vard TJ, Puntis MC, Lewis WG. Prospective multi-\n    centre randomised controlled trial of early ente-\n    ral nutrition for patients undergoing major upper\n    gastrointestinal surgical resection. Clin Nutr.\n    2011; 30:560-6.\n90. Wright GP, Foster SM, Chung MH. Esophagec-\n    tomy in patients with prior percutaneous endos-\n    copic gastrostomy tube placement. Am J Surg.\n    2014; 207:361-5.\n91. Choi AH, O'Leary MP, Merchant SJ, Sun V, Chao\n    J, Raz DJ, et al. Complications of Feeding Jejunos-\n    tomy Tubes in Patients with Gastroesophageal\n    Cancer. J Gastrointest Surg. 2017; 21:259-65.\n92. Bowen TS, Schuler G, Adams V. Skeletal muscle\n    wasting in cachexia and sarcopenia: molecular\n    pathophysiology and impact of exercise training.\n    J Cachexia Sarcopenia Muscle. 2015; 6:197-207.\n93. LÃ¸nbro S. The effect of progressive resistance tra-\n    ining on lean body mass in post-treatment can-\n    cer patients - a systematic review. Radiother On-\n    col. 2014; 110:71-80.\n94. Martin L, Lagergren P. Risk factors for weight loss\n    among patients surviving 5 years after esopha-\n    geal cancer surgery. Ann Surg Oncol. 2015; 22:\n    610-6.\n95. Martin L, Lagergren P. Long-term weight chan-\n    ge after oesophageal cancer surgery. Br J Surg.\n    2009; 96:1308-14.\n96. D'Journo XB, Ouattara M, Loundou A, Trousse D,\n    Dahan L, Nathalie T, et al. Prognostic impact of\n    weight loss in 1-year survivors after transthoracic\n    esophagectomy for cancer. Dis Esophagus. 2012;\n    25:527-34.\n97. Koizumi M, Hosoya Y, Dezaki K, Yada T, Hosoda\n    H, Kangawa K, et al. Postoperative weight loss\n    does not resolve after esophagectomy despite\n    normal serum ghrelin levels. Ann Thorac Surg.\n    2011; 91:1032-7.\n98. Miyazaki T, Tanaka N, Hirai H, Yokobori T, Sano\n    A, Sakai M, et al. Ghrelin level and body weight\n    loss after esophagectomy for esophageal cancer.\n    J Surg Res. 2012; 176:74-8.\n99. Doki Y, Takachi K, Ishikawa O, Miyashiro I, Sasaki\n    Y, Ohigashi H, et al. Ghrelin reduction after eso-\n    phageal substitution and its correlation to posto-\n    perative body weight loss in esophageal cancer\n    patients. Surgery. 2006; 139:797-805.\n100. Karagianni VT, Papalois AE, Triantafillidis JK. Nu-\n     tritional status and nutritional support before\n     and after pancreatectomy for pancreatic cancer\n     and chronic pancreatitis. Indian J Surg Oncol.\n     2012; 3: 348-59.\n101. Kim SY, Wie GA, Lee WJ, Park SJ, Woo\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>CANCER<|>EVENT<|>Cancer is a disease characterized by uncontrolled cell growth, which is the focus of various studies and trials mentioned in the text.)\n##\n(\"entity\"<|>ESOPHAGEAL CANCER<|>EVENT<|>Esophageal cancer is a type of cancer that affects the esophagus, and it is the subject of multiple studies regarding nutritional support and surgical outcomes.)\n##\n(\"entity\"<|>NUTRITIONAL SUPPORT<|>EVENT<|>Nutritional support refers to the dietary assistance provided to patients, particularly those undergoing surgery for esophageal cancer, to improve recovery outcomes.)\n##\n(\"entity\"<|>SURGERY<|>EVENT<|>Surgery is a medical procedure that is often performed on patients with esophageal cancer, as referenced in the studies discussing postoperative complications and recovery.)\n##\n(\"entity\"<|>RANDOMIZED CONTROLLED TRIAL<|>EVENT<|>A randomized controlled trial is a scientific study design used to test the effectiveness of interventions, such as nutritional support in cancer patients.)\n##\n(\"entity\"<|>MULTICENTER TRIAL<|>EVENT<|>A multicenter trial is a clinical study conducted at several locations, which is relevant to the studies mentioned in the text regarding esophageal cancer.)\n##\n(\"entity\"<|>PROGNOSTIC IMPACT<|>EVENT<|>Prognostic impact refers to the influence of certain factors, such as weight loss, on the outcomes of patients after esophageal cancer surgery.)\n##\n(\"relationship\"<|>ESOPHAGEAL CANCER<|>NUTRITIONAL SUPPORT<|>Nutritional support is associated with improved outcomes in patients undergoing surgery for esophageal cancer<|>8)\n##\n(\"relationship\"<|>SURGERY<|>ESOPHAGEAL CANCER<|>Surgery is a common treatment for esophageal cancer, as indicated in the studies<|>9)\n##\n(\"relationship\"<|>RANDOMIZED CONTROLLED TRIAL<|>MULTICENTER TRIAL<|>Both randomized controlled trials and multicenter trials are methodologies used to assess the effectiveness of treatments in cancer research<|>7)\n##\n(\"relationship\"<|>PROGNOSTIC IMPACT<|>ESOPHAGEAL CANCER<|>The prognostic impact of weight loss is studied in the context of esophageal cancer surgery outcomes<|>6)\n<|COMPLETE|>"}]}